PFO closure reduces recurrent strokes – a therapeutic promise is finally kept
22 May 2017
In patients with a patent foramen ovale (PFO) and cryptogenic stroke, percutaneous closure of the PFO has long been postulated to reduce the rate of recurrent strokes. However, up until now, trial data has failed to convincingly deliver a message of benefit for such an approach. Although the wait has been long, two recently reported trials finally seem to deliver on the therapeutic promise of PFO closure.
EuroPCR 2017 Highlights: Interventions for Stroke
20 May 2017 From EUROPCR 2017
Interventional treatment of stroke is the future! M. Roffi and Ö. Göktekin along with L. N. Hopkins, neurosurgeon, explain how interventional cardiologists can respond to this challenge. Robust data supporting mechanical treatment of acute stroke increases daily. Until recently we believed intervention worked only within a 6 hour window, but now, the newly released DAWN trial shows that patient selection, IV r-tPA + clot retrieval can have a positive benefit for up to 24 hours after a stroke. An army of interventionalists is needed to treat the millions of eligible patients!
Carotid stenting: advanced and novel strategies
19 May 2017 – From EuroPCR 2017
Trials for peripheral intervention and stroke prevention
18 May 2017 – From EuroPCR 2017
Management of multidistrict atherosclerotic patients and concomitant disease
18 May 2017 – From EuroPCR 2017
Emerging strategies for carotid angioplasty
17 May 2017 – From EuroPCR 2017
Carotid stenting, present and future
What is the role of carotid artery stenting? Can it be considered today as a first choice in the treatment of critical bifurcation carotid stenosis? M. Roffi and A. Cremonesi explore the different dimensions of this procedure, its history, devices, operator experience, as well as existing limitations and challenges. What technological innovations hold promise and what do we expect from the future? Join us …
IFR-SWEDEHEART and DEFINE-FLAIR: iFR vs. FFR
Join W. Wijns as he explores issues surrounding the adoption of iFR or FFR as highlighted by two trials presented at ACC2017 – IFR-SWEDEHEART, from the well-known Swedish registry and DEFINE-FLAIR. Can the design of these trials shed light on the efficacy of either of these physiologic measurements? What important, and previously missing data, was finally reported? And the results of these trials – what impact will they have on the way you practice? Join us and find out…
This interview was recorded at the American College of Cardiology Scientific Sessions 2017 (ACC.17).
LIVE case: transradial right internal carotid artery stenting
From PCR PERIPHERAL 2016
Consult this LIVE case on transradial right internal carotid artery stenting if you want to learn more about the utility of a transradial approach for endovascular interventions, Micromesh technology for carotid artery treatment and the value of imaging.
A 75-year-old male with a significative right internal carotid artery stenosis:Intraprocedural transcranial doppler monitoringRadial accessProtection deviceDirect stenting
This LIVE transmission was transmitted via Web technology.
LIVE case: right internal carotid stenting and FFR of LAD
From EUROPCR 2016
Consult the LIVE case on right internal carotid stenting and FFR of LAD if you want to learn more about symptomatic right internal carotid artery stenosis in proximal LAD disease - a fully percutaneous approach.
A 63-year-old female with concomitant carotid and coronary artery disease:Assessment by FRR of LADFull protect procedure of carotid artery